Prevalence and Prognostic Impact of Metabolic Syndrome in Asymptomatic (Stage A and B Heart Failure) Patients.

@article{Carrubba2016PrevalenceAP,
  title={Prevalence and Prognostic Impact of Metabolic Syndrome in Asymptomatic (Stage A and B Heart Failure) Patients.},
  author={Salvatore La Carrubba and Francesco Antonini-Canterin and Iacopo Fabiani and Paolo Colonna and Nicola Riccardo Pugliese and Pio Caso and Lorenzo Conte and Frank Antonio Benedetto and Concetta Zito and Rodolfo Citro and Scipione Carerj and Vitantonio Di Bello},
  journal={Metabolic syndrome and related disorders},
  year={2016},
  volume={14 3},
  pages={187-94}
}
BACKGROUND Metabolic syndrome (MS) has an increased risk of cardiovascular events. Its relationship with asymptomatic left ventricular dysfunction (LVD) and prognosis has not been completely clarified. OBJECTIVES To determine, in asymptomatic patients (Stage A, B heart failure, HF), whether MS is associated with left ventricular systolic dysfunction (LVSD… CONTINUE READING